scispace - formally typeset
Open AccessJournal ArticleDOI

Organization of human immunoglobulin heavy chain diversity gene loci.

Ichihara Y, +2 more
- 20 Dec 1988 - 
- Vol. 7, Iss: 13, pp 4141-4150
TLDR
A new kind of DH gene is found (which is termed DIR) the spacer lengths of whose neighbouring signals were irregular, and appears to be involved in DIR‐DH or DH‐DIR joining by inversion or deletion.
Abstract
The variable region of immunoglobulin heavy chain is encoded by three separate genes on the germline genome: variable (VH), diversity (DH) and joining (JH) genes. Most human DH genes are encoded in 9-kb repeating sequences. We determined the nucleotide sequence of a 15-kb DNA fragment containing more than one and a half of these repeating units, and identified 12 different DH genes. Based on the sequence similarities of DH coding and the surrounding regions, they can be classified into six different DH gene families (DXP, DA, DK, DN, DM and DLR). Nucleotide sequences of DH genes belonging to different families diverge greatly, while those belonging to the same families are well conserved. Since the 9-kb DNA containing the six DH genes are multiplied at least five times, the total number of DH genes must be approximately 30. These DH genes are sandwiched by 12-nucleotide spacer signals. Most of the somatic DH sequences found in the published VH-DH-JH structures (the somatic DH segment being defined as the region which is not encoded either by germline VH or JH gene) were assigned to one of the germline DH genes. Other than these typical DH genes, however, we found a new kind of DH gene (which we termed DIR) the spacer lengths of whose neighbouring signals were irregular. The DIR gene appears to be involved in DIR-DH or DH-DIR joining by inversion or deletion. Two of the somatic DH sequences were assigned to the DIR genes. Long N segments might, therefore, originate from DIR genes.

read more

Citations
More filters
Patent

Transgenic non-human animals capable of producing heterologous antibodies

TL;DR: In this paper, a transgenic non-human animals capable of producing heterologous antibodies and methods for producing human sequence antibodies which bind to human antigens with substantial affinity are described.
Patent

Transgenic non-human animals for producing heterologous antibodies

TL;DR: In this paper, a transgenes containing sequences of unrearranged heterologous human immunoglobulin heavy chains are introduced into a non-human animal, thereby forming a transgenic animal capable of functionally rearranging transgenio-globulin sequences and producing a repertoire of antibodies.
Patent

Transgenic non-human animals capable of producing heterologous antibodies of various isotypes

TL;DR: In this article, a transgenes containing sequences of unrearranged heterologous human immunoglobulin heavy chains are introduced into a non-human animal, thereby forming a transgenic animal capable of functionally rearranging transgenio-globulin sequences and producing a repertoire of antibodies.
Patent

Production of anti-self antibodies from antibody segment repertoires and displayed on phage

TL;DR: In this paper, the authors described methods for the production of anti-self antibodies and antibody fragments, being antibodies or fragments of a particular species of mammal which bind self-antigens of that species.
Related Papers (5)